Updated: MicuRx Pharmaceuticals raises $10M for anti-infection drugs
Updated: See David Hamilton’s at VentureBeat LifeSciences here.
MicuRx Pharmaceuticals, a Union City, Calif. maker of anti-infection drugs, has raised $10 million in a first round of funding from Morningside Group.
Next Story: MicuRx raises $10M for new anti-infectives
Previous Story: Facebook apps are getting bought – land grab in progress?
About the Author, Matt Marshall
Matt Marshall is editor and CEO of VentureBeat. Follow him on Twitter at @mmarshall, and follow VentureBeat on Twitter at @venturebeat.